Page last updated: 2024-08-23

paclitaxel and Cancer of Testis

paclitaxel has been researched along with Cancer of Testis in 78 studies

Research

Studies (78)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.28)18.7374
1990's13 (16.67)18.2507
2000's41 (52.56)29.6817
2010's18 (23.08)24.3611
2020's5 (6.41)2.80

Authors

AuthorsStudies
Bellon, JR; Burstein, HJ; Dang, CT; DeMeo, M; Isakoff, SJ; Krop, IE; Partridge, AH; Tayob, N; Tolaney, SM; Tralins, J; Winer, EP; Yang, DD1
Asher, R; Connolly, EA; Forgeson, G; Goh, J; Grimison, P; Hamad, N; Heller, GZ; Hill, S; Joshi, A; Kuchel, A; Lewin, J; Liow, E; McKenzie, J; Tan, A; Tan, H; Toner, G; Tran, B; Tung, ILY; Walpole, E; Wang, Y; Weickhardt, A; Wickham, A; Winstanley, MA; Wong, V1
Dong, L; Fan, Y; Li, Q; Luo, Y; Ma, F; Wang, J; Wang, X; Xiu, M; Xu, B; Yuan, P; Zhang, P1
Cao, K; Chen, H; Gao, X; Jia, Z; Li, J; Lian, B; Liu, Z; Shao, C; Sun, Y; Wang, L; Wang, T; Wang, W; Xu, J; Yang, Q; Zhang, W1
Lassaletta, A; Madero, L; Moreno-Tejero, ML; Pelaez, I; Perez-Somarriba, M; Rozas, MI1
Albany, C; Costello, BA; Dockter, T; Einhorn, L; Lafky, JM; Le-Rademacher, J; Loprinzi, CL; Ma, C; Pachman, D; Smith, E; Staff, N; Wagner-Johnston, N; Wolfe, E1
Anwer, F; Chan, O; Hamdani, AA; Sokolova, A; Ullah, W1
Richie, JP1
Bastide, C; Bruyère, F; Deville, JL; Flechon, A; Guy, L; Karsenty, G1
Chovanec, M; Mardiak, J; Mego, M; Obertova, J; Palacka, P; Rajec, J; Sycova-Mila, Z1
Badreldin, W; Berney, D; Chowdhury, S; Frampton, AE; Harding, V; Harland, SJ; Krell, J; Mazhar, D; Shamash, J; Stebbing, J; Wilson, P1
Chevreau, C; Culine, S; Delva, R; Eymard, JC; Fizazi, K; Fléchon, A; Geoffrois, L; Gravis, G; Habibian, M; Journeau, F; Kerbrat, P; Laplanche, A; Linassier, C; Logothetis, C; Malhaire, JP; Mardiak, J; Martin, AL; Pagliaro, L; Reckova, M; Rolland, F; Roubaud, G; Theodore, C1
Brames, MJ; Einhorn, LH; Mulherin, BP1
Bokemeyer, C; Cathomas, R; de Wit, M; Dieing, A; Grünwald, V; Hentrich, M; Hornig, M; Lorch, A; Meiler, J; Oechsle, K; Seidel, C1
Bosl, GJ; Feldman, DR; Funt, SA1
Bokemeyer, C; Dyshlovoy, S; Gerwing, M; Hauschild, J; Honecker, F; Jacobsen, C; Oechsle, K; Oing, C; Oldenburg, J; Rohlfing, T; Venz, S; von Amsberg, G1
Alsdorf, WH; Bokemeyer, C; Oechsle, K; Oing, C; von Amsberg, G1
Beyer, J; Lorch, A1
Bokemeyer, C; Kollmannsberger, C1
Biasoni, D; Gianni, L; Milani, A; Necchi, A; Nicolai, N; Piva, L; Pizzocaro, G; Salvioni, R; Stagni, S; Torelli, T1
Abonour, R; Einhorn, LH; Kesler, KA1
Boehlke, I; Bokemeyer, C; Hartmann, JT; Honecker, F; Kollmannsberger, C; Mayer, F; Oechsle, K; Waller, CF1
Hayes, JH; Ho, VT; Hornick, JL; Jagannathan, JP; O'Regan, KN; Ramaiya, N; Sneag, DB1
Kang, WK; Lee, J; Lee, S; Lim, HY; Park, JO; Park, S; Park, SH; Park, YS1
Lim, L; Powles, T; Rashid, S1
Akaza, H; Hattori, K; Hinotsu, S; Kawai, K; Miyazaki, J; Shimazui, T; Tsukamoto, S1
Driver, D; Giles, C; Harland, SJ; Haynes, R; Kanfer, EJ; McNeish, IA; Newlands, ES; Rustin, GJ; Seckl, MJ1
Beyer, J; Bokemeyer, C; Braun, T; Hartmann, JT; Hartmann, M; Pottek, T; Rachud, B; Rick, O; Schirren, J; Siegert, W; Weinknecht, S; Weissbach, L1
Aieta, M; De Giorgi, U; Fochessati, F; Marangolo, M; Paoluzzi, L; Papiani, G; Rosti, G; Valduga, F1
Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Metzner, B; Schleicher, J; Schleucher, N; Wierecky, J1
Argyriou, AA; Chroni, E; Ellul, J; Iconomou, G; Kalofonos, HP; Katsoulas, G; Koutras, A; Papapetropoulos, S1
Biron, P; Bui, B; Caty, A; Culine, S; Curé, H; De Revel, T; Delva, R; Droz, JP; Duclos, B; Fizazi, K; Gligorov, J; Gomez, F; Gravis, G; Guillemaut, S; Lotz, JP; Peny, J; Provent, S; Ségura, C; Théodore, C; Viens, P1
Mikami, K; Miki, T; Mizutani, Y1
Hlavatá, Z; Koza, I; Mardiak, J; Mego, M; Obertová, J; Recková, M; Sálek, T; Sycová-Milá, Z2
Farmakis, D; Pectasides, D; Pectasides, M1
Malkowicz, SB; Rizzo, TA; Vaughn, DJ1
Bacik, J; Bajorin, D; Bosl, GJ; Donadio, A; Kondagunta, GV; Marion, S; Motzer, RJ; Sheinfeld, J1
Rexer, FH1
Mathew, P; Troncoso, P; Vakar-Lopez, F1
Fujisawa, M; Furukawa, J; Hara, I; Kumano, M; Yamada, Y; Yamanaka, K1
Kawauchi, A; Miki, T; Mizutani, Y; Nakamura, T; Nomoto, T1
Kawauchi, A; Mikami, K; Miki, T; Mizutani, Y; Nakamura, T; Nakanishi, H; Nomoto, T1
Fujisawa, M; Hara, I; Miyake, H; Takenaka, A; Yamada, Y1
Brames, MJ; Einhorn, LH; Juliar, B; Williams, SD1
Ansell, W; Berney, D; Mutsvangwa, K; Oliver, T; Powles, T; Shamash, J; Stebbing, J; Walsh, E; Wilson, P1
Brozmanová, K; Hlavatá, Z; Koza, I; Mardiak, J; Mego, M; Obertová, J; Recková, M; Risnyovzská, Z; Sálek, T; Svetlovská, D; Sycová-Milá, Z1
Droz, JP; Fléchon, A1
Fukuda, H; Higashi, Y; Ichiyanagi, N; Ishioka, J; Kageyama, Y1
Inoue, H; Miki, T; Mizutani, Y; Nakayama, M; Nishimura, K; Nonomura, N; Oka, D; Okuyama, A1
Marwaha, S; North, SA; Venner, PM1
Galsky, MD; Kondagunta, V; Sonpavde, G1
Böhlke, I; Bokemeyer, C; Hartmann, JT; Honecker, F; Kollmannsberger, C; Mayer, F; Oechsle, K; Waller, CF1
Beyer, J; Bokemeyer, C; Casper, J; Derigs, G; Gauler, T; Gerl, A; Hartmann, JT; Horger, M; Kuczyk, MA; Mayer-Steinacker, R; Metzner, B; Rick, O; Schleicher, J1
Egawa, S; Hatano, T; Ito, H; Kishimoto, K; Tomita, M; Wada, T; Yanada, S1
Bui, V; Chevreau, C; Delord, JP; Fizazi, K; Flechon, A; Geoffrois, L; Kerbrat, P; Lotz, JP; Theodore, C; Yataqhene, Y1
Necchi, A; Nicolai, N; Salvioni, R1
Bajorin, DF; Bosl, GJ; Fischer, P; Hutter, HS; Lyn, P; Motzer, RJ; Scher, HI; Schwartz, LH1
Eckhardt, S1
Beyer, J; Bokemeyer, C; Knoche, M; Natt, F; Schmoll, HJ; Souchon, R1
Gerl, A; Wilmanns, W1
Beyer, J; Bokemeyer, C; Hartmann, JT; Jonas, U; Kanz, L; Kuczyk, MA; Truss, MC1
Beyer, J; Bokemeyer, C; Harstrick, A; Kohrmann, U; Metzner, B; Ruther, U; Schmoll, HJ; Verbeek, W; Weissbach, L1
Oliver, RT1
Motzer, RJ2
Rowinsky, EK1
Cristou, A; Fox, S; Nichols, CR; Roth, BJ; Sandler, AB; Turns, M; Williams, SD1
Breder, VV; Garin, AM; Kupchan, DZ; Popov, AJ; Sidorova, NJ; Titov, DA; Tjulandin, SA1
de Mulder, PH; de Wit, R; Louwerens, M; Rodenhuis, S; Schornagel, J; Verweij, J1
Akaza, H; Hattori, K1
Bacik, J; Bains, M; Bajorin, D; Bosl, GJ; Mariani, T; Mazumdar, M; Motzer, RJ; Sheinfeld, J1
Berdel, WE; Beyer, J; Bokemeyer, C; Casper, J; Derigs, G; Gerl, A; Hartmann, F; Hartmann, JT; Kanz, L; Kingreen, D; Metzner, B; Neureither, S; Rick, O; Schmoll, HJ; Schwella, N; Siegert, W; Wandt, H1
Beyer, J; Bokemeyer, C; Rick, O; Siegert, W1
Beyer, J; Rick, O; Siegert, W1
Catalano, P; Einhorn, LH; Hinton, S; Kuzel, T; Loehrer, PJ; Vaughn, D; Wilding, G1
Beyer, J; Bokemeyer, C; Hartmann, JT; Jonas, U; Kanz, L; Kollmannsberger, C; Kuczyk, MA; Truss, MC1
Kramer, RE; Mason, JI; Rainey, WE; Shay, JW1

Reviews

20 review(s) available for paclitaxel and Cancer of Testis

ArticleYear
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
    BJU international, 2022, Volume: 130 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Testicular Neoplasms

2022
[Chemotherapy in male external genital organs (testicular and penile cancer)].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2013, Volume: 23, Issue:15

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cryopreservation; Etoposide; Fluorouracil; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Paclitaxel; Penile Neoplasms; Spermatozoa; Testicular Neoplasms; Vinblastine

2013
The Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering Approach.
    Oncology (Williston Park, N.Y.), 2016, Volume: 30, Issue:7

    Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Clinical Trials as Topic; Disease-Free Survival; Evidence-Based Medicine; Humans; Lymph Node Excision; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Patient Selection; Salvage Therapy; Testicular Neoplasms; Treatment Outcome

2016
Platinum-refractory germ cell tumors: an update on current treatment options and developments.
    World journal of urology, 2017, Volume: 35, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Salvage Therapy; Testicular Neoplasms

2017
High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.
    World journal of urology, 2017, Volume: 35, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Patient Selection; Salvage Therapy; Testicular Neoplasms; Vinblastine

2017
Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
    Current opinion in supportive and palliative care, 2008, Volume: 2, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prognosis; Testicular Neoplasms; Time Factors; Treatment Failure; Urogenital Surgical Procedures; Vinblastine

2008
Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.
    Current treatment options in oncology, 2012, Volume: 13, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms; Therapeutic Equipoise

2012
[The second-line chemotherapy for urological cancers].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Male; Methotrexate; Paclitaxel; Survival Rate; Testicular Neoplasms; Treatment Outcome; Urologic Neoplasms; Vinblastine

2005
Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
    European urology, 2005, Volume: 48, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Ifosfamide; Irinotecan; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Vinblastine

2005
[Progress in therapy for testicular tumors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Camptothecin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Irinotecan; Lymph Node Excision; Male; Paclitaxel; Taxoids; Testicular Neoplasms

2006
High-dose chemotherapy for male germ cell tumor.
    International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Humans; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms

2006
[Testis germ cell tumours: which chemotherapy, for which patients?].
    Annales d'urologie, 2007, Volume: 41, Issue:2

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Positron-Emission Tomography; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Seminoma; Testicular Neoplasms; Testis; Vinblastine

2007
[Use of taxol in the management of malignant tumors].
    Orvosi hetilap, 1995, Sep-10, Volume: 136, Issue:37

    Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Male; Neoplasms; Ovarian Neoplasms; Paclitaxel; Testicular Neoplasms

1995
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors.
    World journal of urology, 1996, Volume: 14, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Germinoma; Humans; Male; Paclitaxel; Testicular Neoplasms; Urinary Bladder Neoplasms

1996
Future trials in germ cell malignancy (GCM) of the testis.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1997, Volume: 23, Issue:2

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials as Topic; Decision Making; Etoposide; Forecasting; Genetic Therapy; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Orchiectomy; Paclitaxel; Patient Participation; Quality of Life; Risk Factors; Safety; Salvage Therapy; Seminoma; Testicular Neoplasms

1997
Paclitaxel pharmacology and other tumor types.
    Seminars in oncology, 1997, Volume: 24, Issue:6 Suppl 19

    Topics: Alkylating Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Endometrial Neoplasms; Esophageal Neoplasms; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphoma; Male; Neoplasms; Neoplasms, Unknown Primary; Paclitaxel; Platinum Compounds; Sarcoma, Kaposi; Stomach Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine

1997
Paclitaxel (Taxol) combination therapy for resistant germ cell tumors.
    Seminars in oncology, 2000, Volume: 27, Issue:1 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Germinoma; Humans; Male; Paclitaxel; Remission Induction; Salvage Therapy; Testicular Neoplasms

2000
[New combination chemotherapy in urological cancers].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Gemcitabine; Humans; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Male; Methotrexate; Paclitaxel; Prostatic Neoplasms; Taxoids; Testicular Neoplasms; Urinary Bladder Neoplasms; Vinblastine

2000
Salvage chemotherapy in relapsed germ cell tumors.
    World journal of urology, 2001, Volume: 19, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; Testicular Neoplasms; Vinblastine

2001
Recent strategies for the use of paclitaxel in the treatment of urological malignancies.
    World journal of urology, 1998, Volume: 16, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Humans; Male; Paclitaxel; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms

1998

Trials

25 trial(s) available for paclitaxel and Cancer of Testis

ArticleYear
Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033): A Phase II Randomized Trial of Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab in Women With Stage I HER2-Positive Breast Cancer.
    International journal of radiation oncology, biology, physics, 2022, 05-01, Volume: 113, Issue:1

    Topics: Ado-Trastuzumab Emtansine; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Male; Mastectomy; Neoplasm Recurrence, Local; Paclitaxel; Receptor, ErbB-2; Retrospective Studies; Testicular Neoplasms; Trastuzumab

2022
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    The Lancet. Oncology, 2014, Volume: 15, Issue:13

    Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; International Agencies; Lenograstim; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Precision Medicine; Prognosis; Recombinant Proteins; Survival Rate; Testicular Neoplasms; Young Adult

2014
Paclitaxel, ifosfamide and cisplatin regimen is feasible for Japanese patients with advanced germ cell cancer.
    Japanese journal of clinical oncology, 2003, Volume: 33, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Feasibility Studies; Humans; Ifosfamide; Leukopenia; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Taxoids; Testicular Neoplasms

2003
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.
    British journal of cancer, 2004, Mar-22, Volume: 90, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Germinoma; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Outcome

2004
Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experience.
    American journal of clinical oncology, 2004, Volume: 27, Issue:5

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Germinoma; Humans; Male; Mediastinal Neoplasms; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Survival Analysis; Testicular Neoplasms

2004
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial.
    Neurology, 2005, Jan-11, Volume: 64, Issue:1

    Topics: Administration, Oral; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Pilot Projects; Testicular Neoplasms; Uterine Cervical Neoplasms; Vitamin E

2005
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome

2005
Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study.
    Neoplasma, 2005, Volume: 52, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Germinoma; Humans; Male; Neoplasm Recurrence, Local; Paclitaxel; Testicular Neoplasms; Treatment Outcome

2005
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Sep-20, Volume: 23, Issue:27

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Germinoma; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Patient Selection; Probability; Prognosis; Prospective Studies; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Outcome

2005
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.
    Neoplasma, 2005, Volume: 52, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Germinoma; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Gonadal Tissue; Paclitaxel; Prognosis; Prospective Studies; Retroperitoneal Neoplasms; Salvage Therapy; Testicular Neoplasms; Treatment Outcome

2005
Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Feb-10, Volume: 25, Issue:5

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Humans; Indiana; Kaplan-Meier Estimate; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Time Factors; Treatment Failure; Treatment Outcome

2007
A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Follow-Up Studies; Humans; Irinotecan; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Survival Analysis; Testicular Neoplasms; Time Factors; Topoisomerase I Inhibitors; Treatment Outcome

2007
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
    Neoplasma, 2007, Volume: 54, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Choriocarcinoma; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Prospective Studies; Teratocarcinoma; Testicular Neoplasms

2007
Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
    International journal of urology : official journal of the Japanese Urological Association, 2007, Volume: 14, Issue:6

    Topics: Acute Kidney Injury; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Treatment Outcome

2007
Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:3

    Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Feasibility Studies; Gemcitabine; Humans; Leukopenia; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome

2008
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Dec-20, Volume: 25, Issue:36

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Survival Analysis; Testicular Neoplasms

2007
A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Recurrence; Testicular Neoplasms

2008
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:11

    Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Male; Mediastinal Neoplasms; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Prognosis; Salvage Therapy; Testicular Neoplasms; Vaginal Neoplasms

1994
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
    Journal of cancer research and clinical oncology, 1994, Volume: 120, Issue:12

    Topics: Adult; Cisplatin; DNA Damage; Drug Resistance; Germinoma; Humans; Male; Paclitaxel; Testicular Neoplasms

1994
Paclitaxel in salvage therapy for germ cell tumors.
    Seminars in oncology, 1997, Volume: 24, Issue:5 Suppl 15

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Cells; Carboplatin; Cisplatin; Cohort Studies; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Testicular Neoplasms; Treatment Outcome

1997
A phase II trial of paclitaxel in refractory germ cell tumors.
    Cancer, 1998, Apr-01, Volume: 82, Issue:7

    Topics: Adolescent; Adult; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Testicular Neoplasms; Treatment Outcome

1998
Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEP.
    International journal of cancer, 1999, Dec-10, Volume: 83, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Germinoma; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Testicular Neoplasms

1999
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy; Taxoids; Testicular Neoplasms; Treatment Outcome

2000
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jan-01, Volume: 19, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Germany; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Survival Rate; Testicular Neoplasms; Thiotepa

2001
Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Apr-01, Volume: 20, Issue:7

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Germinoma; Humans; Infusions, Intravenous; Male; Ovarian Neoplasms; Paclitaxel; Seminoma; Testicular Neoplasms; Treatment Outcome; United States

2002

Other Studies

33 other study(ies) available for paclitaxel and Cancer of Testis

ArticleYear
Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple-negative breast cancer: A prospective cohort study with propensity-matched analysis.
    International journal of cancer, 2022, 08-15, Volume: 151, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Humans; Male; Neoadjuvant Therapy; Paclitaxel; Prospective Studies; Testicular Neoplasms; Treatment Outcome; Triple Negative Breast Neoplasms

2022
Clinical Benefit of Sorafenib Combined with Paclitaxel and Carboplatin to a Patient with Metastatic Chemotherapy-Refractory Testicular Tumors.
    The oncologist, 2019, Volume: 24, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Humans; Male; Neoplasm Metastasis; Paclitaxel; Sorafenib; Testicular Neoplasms; Young Adult

2019
Gemcitabine, paclitaxel, and oxaliplatin (GEMPOX) in the treatment of relapsed/refractory intracranial nongerminomatous germ cell tumors.
    Pediatric blood & cancer, 2020, Volume: 67, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Oxaliplatin; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms

2020
Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Testicular Neoplasms; Young Adult

2021
Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report.
    Journal of medical case reports, 2017, Apr-11, Volume: 11, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fluid Therapy; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Rhabdomyolysis; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome; Young Adult

2017
Re: Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients with Intermediate- or Poor-Risk Germ Cell Tumors.
    The Journal of urology, 2017, Volume: 198, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Treatment Outcome

2017
Adenocarcinoma of the rete testis - a rare case of testicular malignancy.
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2014, Volume: 27, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Rete Testis; Testicular Neoplasms

2014
The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.
    BJU international, 2016, Volume: 117, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-Free Survival; Drug Resistance, Neoplasm; Humans; Irinotecan; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Seminoma; Testicular Neoplasms; Treatment Outcome; Young Adult

2016
Long-term survival with paclitaxel and gemcitabine for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.
    American journal of clinical oncology, 2015, Volume: 38, Issue:4

    Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Longitudinal Studies; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Remission Induction; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Testicular Neoplasms; Treatment Outcome

2015
Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study Group.
    Urologic oncology, 2016, Volume: 34, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Registries; Retrospective Studies; Survival Analysis; Testicular Neoplasms

2016
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells.
    Journal of cancer research and clinical oncology, 2016, Volume: 142, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Humans; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Taxoids; Testicular Neoplasms

2016
Long-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumours.
    BJU international, 2009, Volume: 104, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Epidemiologic Methods; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Remission Induction; Salvage Therapy; Survivors; Testicular Neoplasms; Treatment Outcome

2009
Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ cell tumors: benefit from chemotherapy, surgery, or both?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Dec-10, Volume: 28, Issue:35

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Testicular Neoplasms

2010
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors.
    European urology, 2011, Volume: 60, Issue:4

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Treatment Outcome; Young Adult

2011
Peritoneal relapse of testicular seminomatous germ cell tumor treated successfully with salvage chemotherapy and autologous stem cell transplantation.
    Clinical genitourinary cancer, 2011, Volume: 9, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Ifosfamide; Male; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Salvage Therapy; Seminoma; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous

2011
Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
    Onkologie, 2011, Volume: 34, Issue:8-9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Seminoma; Testicular Neoplasms; Young Adult

2011
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Sep-15, Volume: 22, Issue:18

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Necrosis; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retroperitoneal Neoplasms; Retrospective Studies; Testicular Neoplasms

2004
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
    Journal of cancer research and clinical oncology, 2005, Volume: 131, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Follow-Up Studies; Germany; Germinoma; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Translocation, Genetic; Transplantation, Autologous

2005
Chemosensitivity of malignant ovarian-type surface epithelial tumor of testis.
    Urology, 2005, Volume: 66, Issue:3

    Topics: Adult; Antineoplastic Agents; Carboplatin; Carcinoma, Papillary; Female; Humans; Male; Ovary; Paclitaxel; Testicular Neoplasms

2005
[International study on testicular cancer: EORTC 30983: randomized phase II/III study of Taxol-BEP versus BEP in patients with Intermediate Prognosis Germ Cell Cancer].
    Der Urologe. Ausg. A, 2005, Volume: 44, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Etoposide; Humans; Internationality; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Randomized Controlled Trials as Topic; Testicular Neoplasms; Treatment Outcome

2005
Protracted remission of metastatic epithelioid angiosarcoma with weekly infusion of doxorubicin, paclitaxel, and cisplatin.
    The Lancet. Oncology, 2006, Volume: 7, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diagnosis, Differential; Doxorubicin; Hemangiosarcoma; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Testicular Neoplasms; Treatment Outcome

2006
High dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation for male germ cell tumor. Preliminary report.
    International journal of urology : official journal of the Japanese Urological Association, 2005, Volume: 12, Issue:12

    Topics: Adult; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Feasibility Studies; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms

2005
[Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2006, Volume: 97, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Organoplatinum Compounds; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia

2006
Incorporation of TIP (paclitaxel, ifosfamide, cisplatin) into first-line therapy for intermediate to poor risk testicular germ cell tumors with unfavorable marker decline after initial two cycles chemotherapy: a report of three cases.
    International journal of urology : official journal of the Japanese Urological Association, 2007, Volume: 14, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Risk Factors; Testicular Neoplasms

2007
The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
    The Canadian journal of urology, 2007, Volume: 14, Issue:5

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bleomycin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Secondary Prevention; Testicular Neoplasms; Treatment Outcome

2007
Germ-cell tumors.
    The New England journal of medicine, 2007, Oct-25, Volume: 357, Issue:17

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Remission Induction; Salvage Therapy; Testicular Neoplasms

2007
[A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin].
    Hinyokika kiyo. Acta urologica Japonica, 2008, Volume: 54, Issue:1

    Topics: Adult; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Splenic Neoplasms; Testicular Neoplasms

2008
Does oxaliplatin and paclitaxel combination show an activity of some extent in pretreated patients with germ-cell tumors?: Reply to the article "A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who fail
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Testicular Neoplasms

2008
Antitumor activity of paclitaxel after failure of high-dose chemotherapy in a patient with late relapse of a non-seminomatous germ cell tumor.
    Anti-cancer drugs, 1996, Volume: 7, Issue:6

    Topics: Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Embryonal; Humans; Leukopenia; Male; Paclitaxel; Peripheral Nervous System Diseases; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia

1996
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Drug Resistance, Neoplasm; Germinoma; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Testicular Neoplasms

1996
Paclitaxel and cisplatin as salvage treatment in patients with non-seminomatous germ cell tumour who failed to achieve a complete remission on induction chemotherapy.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:5

    Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Dysgerminoma; Humans; Male; Paclitaxel; Remission Induction; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Failure; Treatment Outcome

1998
Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
    Cancer treatment reviews, 2001, Volume: 27, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etoposide; Germinoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms; Vinblastine

2001
The effects of taxol, a microtubule-stabilizing drug, on steroidogenic cells.
    Journal of cellular physiology, 1985, Volume: 123, Issue:1

    Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Alkaloids; Animals; Bucladesine; Cattle; Cell Line; Cholesterol; Leydig Cells; Male; Mice; Microtubules; Mitochondria; Paclitaxel; Pregnenolone; Progesterone; Steroids; Testicular Neoplasms

1985